DNA-Encoded Library Screening To Inform Design of a Ribonuclease Targeting Chimera (RiboTAC).

Ribonuclease targeting chimeras (RiboTACs) induce degradation of an RNA target by facilitating an interaction between an RNA and a ribonuclease (RNase). We describe the screening of a DNA-encoded library (DEL) to identify binders of monomeric RNase L to provide a compound that induced dimerization of RNase L, activating its ribonuclease activity. This compound was incorporated into the design of a next-generation RiboTAC that targeted the microRNA-21 (miR-21) precursor and alleviated a miR-21-associated cellular phenotype in triple-negative breast cancer cells. The RNA-binding module in the RiboTAC is Dovitinib, a known receptor tyrosine kinase (RTK) inhibitor, which was previously identified to bind miR-21 as an off-target. Conversion of Dovitinib into this RiboTAC reprograms the known drug to selectively affect the RNA target. This work demonstrates that DEL can be used to identify compounds that bind and recruit proteins with effector functions in heterobifunctional compounds.

[1]  Jessica L. Childs-Disney,et al.  Transcriptome-Wide Mapping of Small-Molecule RNA-Binding Sites in Cells Informs an Isoform-Specific Degrader of QSOX1 mRNA. , 2022, Journal of the American Chemical Society.

[2]  Jessica L. Childs-Disney,et al.  Reprogramming of Protein-Targeted Small-Molecule Medicines to RNA by Ribonuclease Recruitment. , 2021, Journal of the American Chemical Society.

[3]  A. Keefe,et al.  Bispecific Estrogen Receptor α Degraders Incorporating Novel Binders Identified Using DNA-Encoded Chemical Library Screening. , 2021, Journal of medicinal chemistry.

[4]  A. Ciulli,et al.  E3 Ligase Ligands for PROTACs: How They Were Found and How to Discover New Ones , 2020, SLAS discovery : advancing life sciences R & D.

[5]  M. Baud,et al.  Current strategies for the design of PROTAC linkers: a critical review , 2020, Exploration of targeted anti-tumor therapy.

[6]  R. Silverman,et al.  A phenolic small molecule inhibitor of RNase L prevents cell death from ADAR1 deficiency , 2020, Proceedings of the National Academy of Sciences.

[7]  R. Langer,et al.  Advances in oligonucleotide drug delivery , 2020, Nature Reviews Drug Discovery.

[8]  Jonathan L Chen,et al.  Design, Optimization, and Study of Small Molecules That Target Tau Pre-mRNA and Affect Splicing. , 2020, Journal of the American Chemical Society.

[9]  Eric T. Wang,et al.  Small-molecule targeted recruitment of a nuclease to cleave an oncogenic RNA in a mouse model of metastatic cancer , 2020, Proceedings of the National Academy of Sciences.

[10]  C. Crews,et al.  Proteolysis-Targeting Chimeras as Therapeutics and Tools for Biological Discovery , 2020, Cell.

[11]  John A. Tallarico,et al.  Harnessing the Anti-Cancer Natural Product Nimbolide for Targeted Protein Degradation , 2018, bioRxiv.

[12]  B. Cravatt,et al.  Electrophilic PROTACs that degrade nuclear proteins by engaging DCAF16 , 2018, bioRxiv.

[13]  Hafeez S Haniff,et al.  Approved Anti-cancer Drugs Target Oncogenic Non-coding RNAs. , 2018, Cell chemical biology.

[14]  M. Disney,et al.  Small Molecule Targeted Recruitment of a Nuclease to RNA. , 2018, Journal of the American Chemical Society.

[15]  G. Varani,et al.  A Macrocyclic Peptide Ligand Binds the Oncogenic MicroRNA-21 Precursor and Suppresses Dicer Processing. , 2017, ACS chemical biology.

[16]  Sydney Brenner,et al.  DNA-Encoded Compound Libraries as Open Source: A Powerful Pathway to New Drugs. , 2017, Angewandte Chemie.

[17]  C. Tsao,et al.  Emerging role of microRNA-21 in cancer (Review) , 2016 .

[18]  S. L. Le Grice,et al.  Identification of Biologically Active, HIV TAR RNA-Binding Small Molecules Using Small Molecule Microarrays , 2014, Journal of the American Chemical Society.

[19]  J. Donovan,et al.  Structure of Human RNase L Reveals the Basis for Regulated RNA Decay in the IFN Response , 2014, Science.

[20]  Steven M. Gallo,et al.  Sequence-based design of bioactive small molecules that target precursor microRNAs , 2014, Nature chemical biology.

[21]  Y. Yen,et al.  Dovitinib synergizes with oxaliplatin in suppressing cell proliferation and inducing apoptosis in colorectal cancer cells regardless of RAS-RAF mutation status , 2014, Molecular Cancer.

[22]  M. Disney,et al.  Covalent small-molecule-RNA complex formation enables cellular profiling of small-molecule-RNA interactions. , 2013, Angewandte Chemie.

[23]  Dario Neri,et al.  20 years of DNA-encoded chemical libraries. , 2011, Chemical communications.

[24]  I. Andricioaei,et al.  Discovery of selective bioactive small molecules by targeting an RNA dynamic ensemble. , 2011, Nature chemical biology.

[25]  Yan Zhang,et al.  Knockdown of miR-21 in human breast cancer cell lines inhibits proliferation, in vitro migration and in vivo tumor growth , 2011, Breast Cancer Research.

[26]  Anna M. Krichevsky,et al.  miR-21: a small multi-faceted RNA , 2008, Journal of cellular and molecular medicine.

[27]  Matthew D Disney,et al.  Two-dimensional combinatorial screening identifies specific aminoglycoside-RNA internal loop partners. , 2008, Journal of the American Chemical Society.

[28]  Shuomin Zhu,et al.  MicroRNA-21 targets tumor suppressor genes in invasion and metastasis , 2008, Cell Research.

[29]  R. Silverman,et al.  Hepatitis C virus RNA: dinucleotide frequencies and cleavage by RNase L. , 2007, Virus research.

[30]  R. Silverman,et al.  Small-molecule activators of RNase L with broad-spectrum antiviral activity , 2007, Proceedings of the National Academy of Sciences.

[31]  N. Greenfield Using circular dichroism spectra to estimate protein secondary structure , 2007, Nature Protocols.